Alpha Tau Medical Ltd. - Class A

The momentum for this stock is not very good. Alpha Tau Medical Ltd. - Class A is not a good growth stock. Alpha Tau Medical Ltd. - Class A is not very popular among insiders. Alpha Tau Medical Ltd. - Class A is a mediocre stock to choose.
Log in to see more information.

News

Aptus Capital Advisors LLC Boosts Stock Position in Alpha Tau Medical Ltd. (NASDAQ:DRTS)
Aptus Capital Advisors LLC Boosts Stock Position in Alpha Tau Medical Ltd. (NASDAQ:DRTS)

Ticker Report Aptus Capital Advisors LLC grew its holdings in shares of Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) by 83.7% in the second quarter, according to its most recent filing with the Securities...\n more…

Alpha Tau Medical (NASDAQ:DRTS) versus Assure (NASDAQ:IONM) Head-To-Head Review
Alpha Tau Medical (NASDAQ:DRTS) versus Assure (NASDAQ:IONM) Head-To-Head Review

Ticker Report Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) and Assure (NASDAQ:IONM - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two...\n more…

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radio
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radio

Globe Newswire JERUSALEM, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company ) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT...\n more…

Alpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS)
Alpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS)

Ticker Report Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright reduced their FY2024 EPS estimates for shares of Alpha Tau Medical in a report issued on Tuesday, August 20th...\n more…

Alpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC Wainwright
Alpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC Wainwright

Ticker Report HC Wainwright reiterated their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS - Free Report) in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a...\n more…

Buy Rating Reaffirmed for Alpha Tau Medical Ltd Amid Strong Clinical Results and Solid Financial Management
Buy Rating Reaffirmed for Alpha Tau Medical Ltd Amid Strong Clinical Results and Solid Financial Management

TipRanks Financial Blog Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Alpha Tau Medical Ltd (DRTS - Research Report). The associated price target ...\n more…